¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)
Asia-Pacific Clinical Biomarkers Market - Analysis and Forecast, 2023-2033
»óǰÄÚµå : 1501633
¸®¼­Ä¡»ç : BIS Research Inc.
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,950 £Ü 4,061,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,450 £Ü 6,126,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀå ±Ô¸ð´Â 2023³â 32¾ï 8,000¸¸ ´Þ·¯¿¡¼­ ¿¹Ãø ±â°£ µ¿¾È CAGR 9.27%·Î ÃßÀÌÇϰí, 2033³â¿¡´Â 79¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023-2033³â
2023³â Æò°¡ 32¾ï 8,000¸¸ ´Þ·¯
2033³â ¿¹Ãø 79¾ï 5,000¸¸ ´Þ·¯
CAGR 9.27%

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó ¹ÙÀÌ¿À¸¶Ä¿ ½ÃÀåÀº ¹ÙÀÌ¿ÀÅ×Å©³î·¯ÁöÀÇ Áøº¸, ÀÇ·á ÁöÃâ Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡ µîÀ» ¹è°æÀ¸·Î ±Þ¼ÓÈ÷ È®´ëµÇ°í ÀÖ½À´Ï´Ù. Áß±¹, ÀϺ», Àεµ µîÀÇ ±¹°¡µéÀÌ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, ¿¬±¸°³¹ß¿¡ ´ëÇÑ ´ë¾×ÀÇ ÅõÀÚ¿Í È°¹ßÇÑ ÀÓ»ó½ÃÇè Ȱµ¿ÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ¾Ï ¹× ½ÉÇ÷°ü°è Áúȯ°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀº Á¶±â Áø´Ü µµ±¸ ¹× Ç¥Àû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í Çмú±â°ü°ú ¹ÙÀÌ¿ÀÀǾàǰ±â¾÷°úÀÇ Çù·Â°ü°èµµ ½ÃÀå ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Â÷¼¼´ë ½ÃÄö½Ì°ú ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º¿Í °°Àº ÷´Ü±â¼úÀÇ ÅëÇÕÀº ½Å±Ô ¹ÙÀÌ¿À¸¶Ä¿ÀÇ µ¿Á¤°ú °ËÁõÀ» °­È­Çϰí, ¾Æ½Ã¾ÆÅÂÆò¾çÀ» ÀÓ»ó ¹ÙÀÌ¿À¸¶Ä¿ÀÇ Àü¸Á¿¡ À־ Áß¿äÇÑ °ÅÁ¡À¸·Î Çϰí ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÀÓ»ó ¹ÙÀÌ¿À ¸¶Ä¿ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå ¹× ±â¼ú µ¿Çâ, ½ÃÀå ¿µÇâ¿äÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð ÃßÀÌ ¹× ¿¹Ãø, ÁÖ¿ä ±¹°¡º° »ó¼¼ ºÐ¼®, °æÀï ±¸µµ, ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ µî À» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ½ÃÀå

Á¦2Àå ½ÃÀåÀÇ ¹üÀ§

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå Áö¿ª

Á¦6Àå ½ÃÀå : ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Introduction to Asia-Pacific Clinical Biomarkers Market

The Asia-Pacific clinical biomarkers market was valued at $3.28 billion in 2023 and is expected to reach $7.95 billion by 2033, growing at a CAGR of 9.27% between 2023 and 2033. Clinical biomarkers are quantifiable biological parameters that aid in understanding the progression and early diagnosis of diseases. These biomarkers, particularly molecular ones, offer new targets for characterizing diseases and for drug discovery and development.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$3.28 Billion
2033 Forecast$7.95 Billion
CAGR9.27%

Market Introduction

The Asia-Pacific (APAC) clinical biomarkers market is rapidly expanding, driven by advancements in biotechnology, increased healthcare spending, and a growing focus on personalized medicine. Countries like China, Japan, and India are at the forefront, with substantial investments in research and development and robust clinical trial activities. The rising prevalence of chronic diseases, such as cancer and cardiovascular conditions, fuels the demand for early diagnostic tools and targeted therapies. Government initiatives and collaborations between academic institutions and biopharmaceutical companies further propel market growth. The integration of advanced technologies, such as next-generation sequencing and bioinformatics, enhances the identification and validation of novel biomarkers, making the APAC region a crucial player in the clinical biomarkers landscape.

Market Segmentation:

Segmentation 1: by Country

How Can This Report Add Value to an Organization?

Growth/Marketing Strategy: Product launches and upgradations accounted for the maximum number of key developments. Numerous synergistic activities, fundings, and acquisitions of the market have also been tracked during the same time period.

Competitive Strategy: The clinical biomarkers market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the Asia-Pacific clinical biomarkers market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are

Table of Contents

Executive Summary

1 Market

2 Market Scope

3 Research Methodology

4 Market Overview

5 Region

6 Market - Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â